1. Considerations on the Calculation of the Human Equivalent Dose from Toxicology Studies for Biologic Anticancer Agents

   • Mohamed Elmeliegy
   • Chandrasekhar Udata
   • Donghua Yin

   Editorial Open access 02 March 2021 Pages: 563 - 567

   

2. Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of Remdesivir, a SARS-CoV-2 Replication Inhibitor

   • Rita Humeniuk
   • Anita Mathias
   • Polina German

   Review Article Open access 30 March 2021 Pages: 569 - 583

   

3. Drug-Metabolizing Cytochrome P450 Enzymes Have Multifarious Influences on Treatment Outcomes

   • Yurong Song
   • Chenxi Li
   • Yuanyan Liu

   Review Article 16 March 2021 Pages: 585 - 601

   

4. Supra-therapeutic Linezolid Trough Concentrations in Elderly Patients: A Call for Action?

   • Dario Cattaneo
   • Marta Fusi
   • Emilio Clementi

   Original Research Article 12 November 2020 Pages: 603 - 609

   

5. Clinical Pharmacokinetics and Bayesian Estimators for the Individual Dose Adjustment of a Generic Formulation of Tacrolimus in Adult Kidney Transplant Recipients

   • Pierre Marquet
   • Alexandre Destère
   • Jean Debord

   Original Research Article 24 November 2020 Pages: 611 - 622

   

6. Dose Adjustment of Quetiapine and Aripiprazole for Pregnant Women Using Physiologically Based Pharmacokinetic Modeling and Simulation

   • Liang Zheng
   • Shiwei Tang
   • Ling Wang

   Original Research Article 30 November 2020 Pages: 623 - 635

   

7. Application of Physiologically Based Pharmacokinetic Modeling to Predict the Effect of Renal Impairment on the Pharmacokinetics of Olanzapine and Samidorphan Given in Combination

   • Lei Sun
   • Lisa von Moltke
   • Karen Rowland Yeo

   Original Research Article Open access 14 December 2020 Pages: 637 - 647

   

8. Rethinking the Application of Pemetrexed for Patients with Renal Impairment: A Pharmacokinetic Analysis

   • Nikki de Rouw
   • Rene J. Boosman
   • Rob ter Heine

   Original Research Article Open access 09 January 2021 Pages: 649 - 654

   

9. Population Pharmacokinetics of Levetiracetam in Patients with Traumatic Brain Injury and Subarachnoid Hemorrhage Exhibiting Augmented Renal Clearance

   • Fekade Bruck Sime
   • Jason A. Roberts
   • Menino Osbert Cotta

   Original Research Article 11 January 2021 Pages: 655 - 664

   

10. Limited Systemic Exposure with Topical Glycopyrronium Tosylate in Primary Axillary Hyperhidrosis

    • David M. Pariser
    • Edward L. Lain
    • Diane R. Mould

    Original Research Article Open access 12 January 2021 Pages: 665 - 676

    

11. Comment on: "Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II”

    • Swantje Völler
    • Robert B. Flint
    • Catherijne A. J. Knibbe

    Letter to the Editor 13 March 2021 Pages: 677 - 679

12. Authors’ Reply to Völler et al: “Comment on: Preterm Physiologically Based Pharmacokinetic Model, Part I and Part II”

    • Khaled Abduljalil
    • Xian Pan
    • Trevor N. Johnson

    Letter to the Editor 13 March 2021 Pages: 681 - 683